Table 1.
Phase I - Cyp | Phase II - Ugt | Phase II - Gst | |||
---|---|---|---|---|---|
Human | Murine | Human | Murine | Human | Murine |
CYP2A6‡†, CYP2A7 | Cyp2a4,Cyp2a5 | UGT1A4* | Ugt1a5 | GSTA3 | Gsta3 |
CYP2F1‡ | Cyp2f2 | UGT1A1 | Ugt1a1 | GSTA4 | Gsta4 |
CYP2S1 | Cyp2s1 | UGT1A6 | Ugt1a6a | GSTP1 | Gstp1 |
CYP4B1 | Cyp4b1 | UGT2B4 | Ugt2b1 | GSTM2 | Gstm2 |
NF (2D6 superfamily)† | Cyp2c29 | NF | Ugt2b5 | GSTM3 | Gstm3 |
NF (3A5 superfamily)‡ | Cyp3a11 | UGT2B10* | Ugt2b34 | GSTM1/M5 | Gstm1 |
CYP8B1 | Cyp8b1 | UGT2B15 | Ugt2b35 | ||
UGT2A3 | Ugt2a3 | ||||
UGT1A9* | Ugt1a9 | ||||
NF | Ugt1a10 | ||||
UGT2B15 | Ugt2b36 |
NF - no ortholog found
Isoforms found to bioactivate NNK to keto alcohol
Isoforms found to bioactivate NNK to keto acid
Isoforms found to glucuronidate NNAL